Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Eli Lilly and Co?

Accepted Answer

Según el último estado financiero (Form-10K), Eli Lilly and Co tiene un total de activos de $78,714, una ganancia neta profit de $10,590

Question 2

¿Cuáles son los ratios financieros clave para LLY?

Accepted Answer

El ratio corriente de Eli Lilly and Co es 1.21, el margen neto es 23.51, las ventas por acción son $49.82.

Question 3

¿Cómo se desglosan los ingresos de Eli Lilly and Co por segmento o geografía?

Accepted Answer

Eli Lilly and Co largest revenue segment is Glucagon, at a revenue of 32,500,000 in the most earnings release.For geography, US Revenue is the primary market for Eli Lilly and Co, at a revenue of 30,375,200,000.

Question 4

¿Es rentable Eli Lilly and Co?

Accepted Answer

yes, según los últimos estados financieros, Eli Lilly and Co tiene una ganancia neta profit de $10,590

Question 5

¿Tiene Eli Lilly and Co alguna deuda?

Accepted Answer

yes, Eli Lilly and Co tiene una deuda de 64,522

Question 6

¿Cuántas acciones en circulación tiene Eli Lilly and Co?

Accepted Answer

Eli Lilly and Co tiene un total de acciones en circulación de 947.53

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	59,419	45,042	34,124	28,541	28,318	24,539
Revenue Growth (YoY)	45%	32%	20%	1%	15%	10%
Cost of Revenue	10,084	8,418	7,082	6,629	7,312	5,483
Gross Profit	49,335	36,624	27,041	21,911	21,005	19,056
Selling, General & Admin	10,387	8,593	7,403	6,440	6,431	6,121
Research & Development	12,558	10,990	9,313	7,190	7,025	6,085
Operating Expenses	22,945	19,584	16,716	13,631	13,457	12,206
Other Non Operating Income (Expenses)	132	436	429	358	341	1,498
Pretax Income	22,503	12,680	6,554	6,806	6,155	7,229
Income Tax Expense	4,091	2,090	1,314	561	573	1,036
Net Income	18,412	10,590	5,240	6,244	5,581	6,193
Net Income Growth	120%	102%	-16%	12%	-10%	-26%
Shares Outstanding (Diluted)	898.8	904.05	903.28	904.61	911.68	912.5
Shares Change (YoY)	-1%	0%	0%	-1%	0%	-2%
EPS (Diluted)	20.48	11.71	5.8	6.9	6.12	6.79
EPS Growth	121%	102%	-16%	13%	-10%	-24%
Free Cash Flow	6,436	414	-3,152	4,600	5,387	4,470
Free Cash Flow Per Share	7.16	0.45	-3.48	5.08	5.9	4.89
Gross Margin	83.02%	81.31%	79.24%	76.77%	74.17%	77.65%
Operating Margin	44.41%	37.83%	30.25%	29.01%	26.65%	27.91%
Profit Margin	30.98%	23.51%	15.35%	21.87%	19.7%	25.23%
Free Cash Flow Margin	10.83%	0.91%	-9.23%	16.11%	19.02%	18.21%
EBITDA	28,286	18,806	11,852	9,802	9,095	8,172
EBITDA Margin	47.6%	41.75%	34.73%	34.34%	32.11%	33.3%
D&A For EBITDA	1,896	1,766	1,527	1,522	1,547	1,323
EBIT	26,390	17,040	10,325	8,280	7,548	6,849
EBIT Margin	44.41%	37.83%	30.25%	29.01%	26.65%	27.91%
Effective Tax Rate	18.17%	16.48%	20.04%	8.24%	9.3%	14.33%

Eli Lilly and Co (LLY) Price

LLY Stock Price Chart

LLY Income

Follow-Up Questions